UPDATE: William Blair Starts Verve Therapeutics (VERV) at Outperform
Tweet Send to a Friend
(Updated - July 12, 2021 6:56 AM EDT)
William Blair analyst Raju Prasad initiates coverage on Verve Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Raju Prasad initiates coverage on Verve Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
